CG
TNDM icon

Cutler Group’s Tandem Diabetes Care TNDM Stock Holding History

Cutler Group’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-100
Closed -$1K – 4724
2022
Q4 		$1K Hold
100
– – ﹤0.01% 4171
2022
Q3 		$1K Buy
+100
New +$5.48K ﹤0.01% 4706
2021
Q3 		– Sell
-4,600
Closed -$20K – 6354
2021
Q2 		$20K Buy
4,600
+4,200
+1,050% +$375K ﹤0.01% 3310
2021
Q1 		$2K Buy
+400
New +$37.2K ﹤0.01% 5019
2019
Q1 		– Sell
-500
Closed -$3K – 4758
2018
Q4 		$3K Hold
500
– – ﹤0.01% 3235
2018
Q3 		$4K Buy
+500
New +$17.5K ﹤0.01% 3222
2016
Q3 		– Sell
-500
Closed -$1K – 7370
2016
Q2 		$1K Buy
+500
New +$40.2K ﹤0.01% 6269

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Cutler Group's TNDM Position: Q1 2023 in Review

Cutler Group sold out of Tandem Diabetes Care (TNDM) in Q1 2023, closing a stake of 171 shares — an estimated $7K sold.

Cutler Group first reported a position in TNDM in Q4 2015 and held it in 17 quarters. The position peaked at $168K in Q1 2022. 273 funds tracked by Wall St. Rank hold TNDM as of Q1 2023.

  • Cutler Group reported no remaining Tandem Diabetes Care position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 171 Tandem Diabetes Care shares in Q1 2023, an estimated $7K.
  • Cutler Group first reported a position in Tandem Diabetes Care in Q4 2015 and held it in 17 quarters.
  • Cutler Group's Tandem Diabetes Care position peaked at $168K in Q1 2022.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.